The Denmark-based Coloplast agreed in January to resolve about 400 suits over the plastic mesh implants which are designed to support internal organs. The settlement is said to provide an average payment of about $40,000 for each claimant.
Dr Shezad Malik Law Firm has offices based in Fort Worth and Dallas and represents people who have suffered catastrophic and serious personal injuries including wrongful death, caused by the negligence or recklessness of others. We specialize in Personal Injury trial litigation and focus our energy and efforts on those we represent.
Articles Tagged with Johnson & Johnson
Report: J&J Ethicon Vaginal Mesh Company Destroyed Crucial Files
Thousands of Ethicon Vaginal Mesh Claims
DePuy ASR Settlement Criteria and Process Explained
Johnson & Johnson Settlement Details
Johnson and Johnson DePuy ASR Finalized Settlement Explained
Johnson & Johnson Under Fire from Lawsuits
The settlement is the second multibillion-dollar settlement this month for J&J. The company, agreed November 4 to pay $2.2 billion to resolve criminal and civil probes into the marketing of Risperdal and other medicines.
Dr Shezad Malik Explains Johnson and Johnson DePuy ASR Hip Implant Settlement
The proposed settlement is going to be presented in federal court and will need the blessing of the federal judge overseeing the DePuy ASR litigation, which at last count has passed the 12,000 mark for folks afflicted by the allegedly faulty hip implant.
$4 Billion J&J DePuy Settles ASR Metal Hip Lawsuits
Settlement Impacts Thousands of Patients
California DePuy ASR Hip Implant Failure Trial Settled
According to court documents, Johnson & Johnson has agreed to settle a DePuy ASR hip replacement lawsuit, on the eve of trial. The settlement agreement remains confidential.
Johnson & Johnson subsidiary DePuy Orthopaedics has agreed to settle a DePuy ASR hip lawsuit, the first bellwether trial in a California state court consolidation of ASR cases.
This DePuy ASR case that was set to begin later in October in California state court. See my earlier reporting on secret settlement negotiations regarding the DePuy ASR implants. This is overall good news for plaintiffs that the company is beginning to take the failure allegations seriously.
Bard, Boston Scientific, Endo Health/AMS Vaginal-Mesh Makers Settlement on the horizon
As a Texas Vaginal Mesh attorney, and Dallas medical doctor, we are reporting this important potential transvaginal mesh settlement breakthrough. According to sources, C.R. Bard Inc., and other makers of vaginal-mesh implants, are in advanced talks to settle thousands of vaginal mesh product liability lawsuits.
Bard, Endo Health Solutions Inc. the parent of AMS, Boston Scientific Corp., Coloplast and Cook Medical Inc. manufacturers making vaginal mesh devices to treat pelvic organ prolapse (POP) and treat stress urinary incontinence (SUI) in talks about settling all suits.
Johnson & Johnson, which also faces suits over the vaginal mesh devices, isn’t involved in the talks.
Bard, Ethicon, Boston Scientific, AMS, Coloplast Vaginal Mesh Litigation
Transvaginal mesh injury lawsuits are consolidated and coordinated in 6 individual multidistrict litigations (MDLs) established in the federal court system. These injury claims against vaginal mesh manufacturers have now become the largest pending litigation in the U.S.
30,000 Active Mesh Lawsuits and Climbing
There are more than 30,000 complaints filed in U.S. District Courts over injuries with transvaginal mesh and bladder sling products. These medical devices have been used for treatment of pelvic organ prolapse (POP) and female stress urinary incontinence (SUI).
Bard Avaulta, Ethicon Gynecare Vaginal Mesh for Prolapse Repair
As a Texas Transvaginal mesh attorney and medical doctor, I am providing details on this latest medical research. According to new published research, transvaginal mesh placement provides no benefits when used for pelvic organ prolapse repair. In a study published in the Obstetrics and Gynecology journal, researchers found that the use of vaginal mesh does not increase good outcome for surgical prolapse repair when compared to more traditional treatments.
The women were followed for three years and the program stopped early because of a 15.6% mesh exposure rate, where the mesh eroded into the vagina.